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Abstract
Background: The emergence of drug resistant pathogens becomes a crucial problem for infectious diseases worldwide.
Among these bacteria, Pseudomonas aeruginosa is one of which highly resists to many currently used drugs
and becomes a major concern in public health. Up till now, the search for potential antimicrobial agents has
been still a challenge for researchers.
Methods: Broth microdilution assay was used to determine minimum inhibitory concentrations (MICs) and
minimum bactericidal concentrations (MBCs) of the essential oils and antibiotics against P. aeruginosa.
Inhibition activity of the essential oils under vapor condition was examined to obtain the minimum inhibitory
dose (MID). Time-kill assay included in this study was performed according to CLSI guideline. Bioautographic assay was
used to detect active components of the essential oil. Synergistic effect with currently used antibiotics was further
examined by checkerboard assay.
Results and Discussion: In this study, a variety of essential oils were examined for anti-multidrug resistant P.
aeruginosa (MDR-PA) activity, of which cinnamon bark oil showed the strongest antimicrobial activity against
all clinical-isolated MDR-PA strains with MIC of 0.0562–0.225 % v/v and MBC of 0.1125–1.8 % v/v.
Bioautographic results demonstrated that the active compounds of cinnamon bark oil were cinnamaldehyde and
eugenol which showed strong inhibitory effect against P. aeruginosa. Interestingly, cinnamaldehyde, a major
constituent of cinnamon bark oil, possessed stronger antimicrobial effect to P. aeruginosa than eugenol. Under gaseous
condition, cinnamon bark oil and cinnamaldehyde showed antibacterial activity against MDR-PA strains with MID of 0.
5–1 mg/L. Moreover, combination of cinnamon bark oil or cinnamaldehyde with currently used antibiotics was
further studied by checkerboard assay to examine synergistic interactions on clinically isolated MDR-PA strains.
Cinnamon bark oil and cinnamaldehyde combined with colistin demonstrated synergistic rates at 16.7 and
10 %, respectively.
Conclusion: These results indicated that cinnamon bark oil and cinnamaldehyde might be active natural compounds
which could be further examined as alternative treatment for multidrug-resistant P. aeruginosa infection.
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Background
Pseudomonas aeruginosa is a Gram-negative non-
fermenting bacterium which has broad ecological
adaptability and distribution. It is an opportunistic hu-
man pathogen, causing severe infections, especially in
immunocompromised patients. This organism is classi-
fied as one of ‘hard to treat’ organisms and is one of
the most antibiotic resistant bacteria in this century
because of its adaptability to various conditions and
multifactorial virulences; for example, endotoxin, exo-
toxin and proteolytic enzymes. In addition, P. aerugi-
nosa has high intrinsic resistance to antibiotic and is
able to develop new antibiotic resistance during
treatment [1]. The ability of antibiotic resistance of P.
aeruginosa is significantly due to low permeability of
the cell wall, which restricts the uptake of antibiotics,
and the genetic capacity to express a wide repertoire of
resistance mechanisms, like efflux pumps and enzymes,
which modify or degrade antibiotics and drug targets
[2]. It was reported that the antibiotic tolerance of P.
aeruginosa clinical isolates could enhance up to 6000-
fold to ciprofloxacin and tobramycin [3–5].
Plant essential oils are potential sources of anti-
microbial compounds and have been used in trad-
itional medicine for many years [6–9]. Essential oils
are natural compounds containing a complex mixture
of odorous and volatile constituents. Essential oils
have been observed to possess antibacterial, antifungal
and anti-plasmodial activity. Several in vitro studies
indicated that essential oils exhibited antibacterial
agents against wide spectrum of pathogenic bacterial
strains [10, 11]. For example, the leaves and flowers
of Achillea clavennae in Croatia were investigated by
disc diffusion method against Gram-positive and
Gram-negative bacteria and showed strong activity
against Haemophilus influenzae and P. aeruginosa.
Also in India, Aristolochia indica containing β-
carophyllene and α-humulene as major components
was evaluated its antibacterial activity against six
strains of bacteria by agar dilution method and dem-
onstrated moderate activity [12]. Some essential oils
such as oregano oil showed effects on multidrug-
resistant Escherichia coli [13]. Antibacterial activities
of the essential oils from Ocimum gratissimum, Salvia
officinalis L, Cymbopogon citratus (DC) stapf were
evaluated on the microorganisms isolated from urin-
ary tract infection and all of these microorganisms
except P. aeruginosa showed sensitivity to these es-
sential oils [14]. Therefore, this study was aimed to
determine the effect of essential oils and its major
compounds against multidrug-resistant P. aeruginosa.
In addition, the combination of essential oils and its
major compounds with currently used antibiotics were
also investigated.
Methods
Bacterial strains, essential oils and antimicrobial agents
Pseudomonas aeruginosa PAO1 and clinically isolated
multidrug-resistant P. aeruginosa (MDR-PA) strains
were cultured in tryptic soy broth (TSB) at 37 °C for 18 h.
The overnight culture was adjusted to an optical density
of 0.5 McFarland and was diluted to yield approximately
1.0 × 106 cfu/ml.
Essential oils used in this study were betel vine oil
(Piper betle Linn.), cinnamon bark oil (Cinnamomum
zeylanicum), citronella oil (Cymbopogon nardus), clove
oil, clove leaf oil (Syzygium aromaticum Linn. (Merr. &
Perry)), galangal oil (Alpinia galangal Linn.), guava leaf
oil (Psidium guajava Linn.), hairy basil oil (Ocimum
americanum Linn.), holy basil oil (Ocimum sanctum
Linn.), kaffir lime oil, kaffir lime leaf oil (Citrus hystrix
DC.), lemon oil (Citrus limonum Linn.), lemongrass oil
(Cymbopogon flexuosus), finger root oil (Boesenbergia
pandurata (Roxb.) Schltr), plai oil (Zingiber cassumunar
Linn.), sweet basil oil (Ocimum bacilicum Linn.), and tur-
meric oil (Curcuma longa Linn.) which were purchased
from Thai-China Flavours and Fragrances Industry Co.,
Ltd, Thailand. Cinnamaldehyde was obtained from S.M.
chemical supplies Co., Ltd, Thailand. The essential oils
and cinnamaldehyde were kept in light protection con-
tainer at 4 °C to prevent oxidative degradation. Tween 80
and 95 % ethanol were used as surfactant and co-
surfactant to prepare essential oil solution. Essential oils
and cinnamaldehyde were dissolved to appropriate con-
centration and stored at 4 °C before testing. Colistin
sulfate was obtained from Acme Medical Co., Ltd,
Thailand. Ceftazidime was purchased from Siam Bheasach
Co., Ltd, Thailand. Imipenem and meropenem were pur-
chased from L.B.S. Laboratory, Thailand. Piperacillin, and
ciprofloxacin were purchased from Shionogi & Co, Japan.
Antimicrobial susceptibility test
Determination of minimum inhibitory concentrations
(MICs) and minimal bactericidal concentrations (MBCs)
of the essential oils and antibiotics against P. aeruginosa
PAO1 and clinical-isolated MDR-PA strains were per-
formed by broth microdilution method as previously
described [15]. MICs were obtained from the lowest
concentration of active compound that inhibited bacter-
ial growth. MBCs were further determined on Mueller-
Hinton agar (MHA) and observed bacterial growth after
18–24 h incubation.
Inhibition activities under vapor condition of cinna-
mon bark oil, lemongrass oil, clove oil and cinnamalde-
hyde were examined on P. aeruginosa PAO1 and 19
MDR-PA isolates. The minimum inhibitory dose (MID)
was defined as the lowest dose per unit space against
bacterial growth. MID was expressed in term of weight
per unit volume (mg/L air). Gaseous phase of essential
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oils were investigated on P. aeruginosa isolates according
to Rodrigues FF et al. [16]. Briefly, essential oils were
dissolved in dimethyl sulfoxide (DMSO) with ratio of 1:1
w/w, and dropped on paper disc. Agar plates were
spread with bacterial suspension containing approxi-
mately 1.5 × 105 cfu/ml before placing paper disc on the
lid of the petri dish and incubated at 37 °C for 24 h
under closed system.
Time killing assay
Cinnamon bark oil and cinnamaldehyde were evaluated
in terms of time killing effect on P. aeruginosa PAO1
and representative MDR-PA strain. Time-kill assay was
performed according to CLSI guideline [17]. The con-
centrations of fosfomycin and carbapenems used in this
assay to determine individual antimicrobial activity were
selected from the Clinical Microbiology Procedures
Handbook protocol [18]. Bacteria were inoculated in
broth medium containing various concentrations of ac-
tive compound as followed, 1xMIC, 2xMIC and 4xMIC.
Treated bacterial cells were evaluated at a certain period
of time by determining the cell viability and the bacterial
growth compared to control.
Thin Layer Chromatography and bioautography
Active components of essential oil were identified by
thin-layer chromatography (TLC). Silica gelGF254 plates
(Merck KGaA, Darmstadt, Germany) were developed in
system of toluene: ethyl acetate at a ratio of 93:7 v/v ac-
cording to Shahverdi et al. [19]. TLC paper coated with
siliga gel was used as a stationary phase. They were de-
veloped in solvent system acting as mobile phase. The
TLC plate was sprayed with 1 % v/v anisaldehyde sul-
furic acid and heated at 110 °C for 5 min before visual-
ized under visible and UV lights (254 and 366 nm). The
constituents of compound were separated and calculated
Rf values. TLC plates were performed in duplicate; one
set was used as the reference chromatogram and another
was used for bioautography. Bioautographic assay was
performed to detect active components in essential oil
[20]. Developed TLC plates were carefully dried to re-
move solvents, overlaid by agar seed, and incubated
overnight at 37 °C. Inhibition zones were compared with
Rf of the spots on the reference TLC plate.
Synergistic activity
The interaction between essential oils and the antibi-
otics, which were ceftazidime (CAZ), piperacilin (PIP),
colistin sulfate (COL), meropenem (MEM), doripenem
(DOR), imipenem (IMI) and ciprofloxacin (CIP), were
determined by combination assay against MDR-PA iso-
lates. Bacteria were cultured in broth medium for 18 h
before adjusted to 0.5 McFarland and the medium was
diluted to obtain the concentration of 1.5 × 106 cfu/ml.
Combination assay were examined in 96-well plate, the
first agent was diluted by two-fold dilution, followed by
adding the second agent at various concentrations.
Then, bacterial suspension was added for into each well
and incubated at 37 °C for 24 h. The fractional inhibitory
concentration index (FICI) was calculated for each
couple of drug combination. FICI was a summation be-
tween MIC of drug A in combination divided by MIC of
drug A alone (CA) and MIC of drug B in combination
divided by MIC of drug B alone (CB).
X
FICI ¼ FICA þ FICB
¼ CA=MICAð Þ þ CB=MICBð Þ
Interpretation criteria of FICI were followed, if FICI ≤
0.5 indicate synergy, FICI between >0.5 and ≤ 4 indicate
indifferent, and FICI > 4 mean antagonism [21].
Results and Discussion
Antimicrobial activity of essential oils against multidrug
resistant P. aeruginosa
Antibacterial activity was performed on 17 essential oils
against P. aeruginosa PAO1.
Three plant oils which were clove oil, lemongrass oil,
and cinnamon bark oil showed effective antimicrobial
activity. Among those, cinnamon bark oil gave the
strongest inhibition activity against P. aeruginosa wild-
type strain with MIC 0.2 % v/v followed by clove oil
and lemongrass oil with MICs of 1.8 % v/v. Other 14
essential oils exhibited low antimicrobial efficacy against
P. aeruginosa with MIC and MBC ranges of more than
1.8–3.6 % v/v. Moreover, cinnamon bark oil was only
essential oil which demonstrated the strongest activity
with MBC at the lowest used concentration (0.2 % v/v). In
addition, cinnamon bark oil, lemongrass oil and clove oil
were further examined on 20 strains of clinical-isolated
MDR-PA strains. Cinnamon bark oil showed the strongest
activity against all MDR-PA isolates with MIC at 0.0562–
0.225 % v/v and MBC at 0.1125–0.225 % v/v. Lemongrass
oil ranked in the second with MIC at 0.45–1.8 % v/v and
MBC varied from 0.9 up to higher than 1.8 % v/v, while
clove oil showed MIC varied from 0.9 up to higher than
1.8 % v/v and MBC was more than 1.8 % v/v (Table 1).
This study indicated that cinnamon bark oil demon-
strated the most inhibitory effectiveness against clinical-
isolated MDR-PA strains with MIC in range of 0.1125 to
0.225 % v/v which was consistent with the previous
study that cinnamon oil was the strongest antimicrobial
agent. The researchers demonstrated that clove and cin-
namon oil possessed potent inhibitory effect on various
bacterial pathogens. Moreover, cinnamon oil showed
promising antimicrobial activity which could inhibit all
tested bacterial strains both Gram-negative and Gram-
positive bacteria with the lowest concentration among
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the total of 21 plant oils [22]. Warnke et al. [23] con-
ducted a study including the activities of various essen-
tial oils using disc diffusion against MDR strains of
Staphylococcus spp., Streptrococcus spp. and Candida
spp. It revealed that thyme, lemon, lemongrass, cinnamon,
tea tree, eucalyptus, grapefruit, clove bud, kunzea, sandal-
wood, peppermint, sage, and lavender oils affected on all
tested microorganisms while olive and paraffin oil showed
no activity. Essential oils from Thai medicinal plants in-
cluding Zingiber cassumuna, Cinnamomum bejolghota,
Mentha arvensis var. piperacens, Cymbopogon citrates,
and Ocimum basilicum var. citratum demonstrated anti-
bacterial activity against zoonotic enteropathogens includ-
ing Salmonella spp., E. coli O157, Campylobacter jejuni,
and Clostridium perfringens [24].
Determination of the active compounds of cinnamon
bark oil
The bioautographic assay was performed to determine the
major active compounds of cinnamon bark oil. The results
showed that cinnamon bark oil contained at least 8 com-
pounds with the major active constituent having Rf of
0.6125 closely to the Rf of the cinnamaldehyde standard.
Another component found in cinnamon bark oil was
eugenol with Rf of 0.5625. The inhibition zones of cinna-
mon bark oil, eugenol and cinnamaldehyde against the
growth of P. aeruginosa PAO1 and MDR-PA isolates were
clearly shown. The clear zones locating separately on TLC
suggested that cinnamon bark oil showed antibacterial ac-
tivity similar to cinnamaldehyde while eugenol showed
lower antibacterial activity than cinnamon bark oil (Fig. 1).
Cinnamaldehyde is considered to be an aromatic alde-
hyde substance found approximately 60–70 % in cinna-
mon bark oil [25]. The results of TLC and bioautographic
assay in this study showed that the major compounds in
cinnamon bark oil were mainly composed of cinnamalde-
hyde and eugenol. Cinnamaldehyde possessed better activ-
ity than eugenol against P. aeruginosa.
Antibacterial activity of cinnamon bark oil and
cinnamaldehyde under gaseous condition
Due to the nature of essential oils being odorous and
volatile, antibacterial activities of the selected essential
Table 1 Susceptibility tests of cinnamon bark oil, lemongrass oil
and clove oil against clinical-isolated MDR-PA strains
Isolated
strain
Cinnamon bark oil Clove oil Lemongrass oil
MIC MBC MIC MBC MIC MBC
(% v/v) (% v/v) (% v/v) (% v/v) (% v/v) (% v/v)
PA01 0.1125 0.225 1.8 >1.8 1.8 >1.8
PA04 0.1125 0.225 1.8 >1.8 1.8 >1.8
PA05 0.1125 0.225 >1.8 >1.8 0.9 0.9
PA07 0.225 1.8 1.8 1.8 1.8 1.8
PA12 0.1125 0.225 >1.8 >1.8 1.8 1.8
PA13 0.225 0.225 1.8 >1.8 1.8 1.8
PA16 0.1125 0.225 1.8 >1.8 0.9 1.8
PA17 0.225 0.225 >1.8 >1.8 1.8 >1.8
PA18 0.1125 0.225 1.8 >1.8 0.9 >1.8
PA19 0.1125 0.225 1.8 >1.8 1.8 >1.8
PA25 0.1125 0.1125 0.9 >1.8 0.45 1.8
PA26 0.1125 0.225 >1.8 >1.8 1.8 >1.8
PA31 0.1125 0.1125 1.8 >1.8 1.8 >1.8
PA34 0.1125 0.225 1.8 >1.8 0.9 >1.8
PA35 0.225 0.225 1.8 >1.8 1.8 >1.8
PA36 0.225 0.225 1.8 >1.8 1.8 >1.8
PA38 0.1125 0.225 1.8 >1.8 0.9 >1.8
PA41 0.0562 0.225 1.8 >1.8 1.8 >1.8
PA43 0.1125 0.225 1.8 >1.8 0.9 1.8
PA45 0.1125 0.1125 1.8 >1.8 1.8 >1.8
Fig. 1 TLC chromatogram of cinnamon bark oil. TLC fingerprints of
essential oils were developed by toluene and ethyl acetate with ratio of
93:7 v/v and visualized under UV light 254 nm (left), 366 nm (center) and
visible light (right) (a). Bioautographic assay against P. aeruginosa was
demonstrated (b). Lane A, cinnamon bark oil; lane B, eugenol; lane C,
cinnamaldehyde. Arrows indicate inhibition zone by active compounds
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oils were also determined under vapor phase condition.
Cinnamon bark oil and cinnamaldehyde demonstrated
promising activity of gas phase against P. aeruginosa
PAO1 and MDR-PA isolates with MID in a range of 0.5
to 1 mg/L air while eugenol, lemongrass and clove oil
showed less inhibition activity with MID more than
1 mg/L air.
Under vapor condition, cinnamon bark oil and cinna-
maldehyde also showed strong activity on MDR-PA.
Some studies on vapor-phase antimicrobial activity of
six essential oils on foodborne pathogens demonstrated
that clove and cinnamon oil possessed more antibacter-
ial activity than rosemary, basil, ginger, and dill oil
against Gram-positive bacteria, Gram-negative bacteria,
and three fungi in disc diffusion method [26]. Moreover,
there was a study of antimicrobial effect of cinnamalde-
hyde on air-borne microbes. The study exhibited that
cinnamaldehyde reduced germ count to 45 % after
sprayed in the room [27].
Time-killing effects of cinnamon bark oil and
cinnamaldehyde
P. aeruginosa PAO1 was challenged with cinnamon bark
oil or cinnamaldehyde at various concentrations and bac-
terial viability was determined at different time points
during incubation. The results showed that bacterial cells
were killed within 1.3 and 2 h after treated with 1xMIC of
cinnamaldehyde and cinnamon bark oil, respectively.
Time-killing graphs demonstrated the reduction of viable
cell approximately 6 log CFU/ml after P. aeruginosa
PAO1 and MDR-PA contacted with the compound for 2
and 4 h, respectively (Fig. 2). Moreover, the higher con-
centrations of cinnamon oil and cinnamaldehyde (4xMIC)
could efficiently eradicate MDR-PA within 1 h. These
results suggested that cinnamon bark oil and cinnamalde-
hyde acted in dose-dependent manner on P. aeruginosa.
Our study also reported that of cinnamon oil and its
major compound at the studied concentrations showed
significant effect on bacterial growth indicating dose-
dependent inhibition activity in agreement with the group
of Mayaud et al. [25].
Synergistic effect of cinnamon bark oil/cinnamaldehyde
and currently used antibiotics
P. aeruginosa PAO1 and 30 clinical isolates of MDR-PA
were determined antimicrobial susceptibility with 7 anti-
biotics for MIC, MIC50 and MIC90 (Table 2). The results
showed that COL had minimal MIC interval at 2–8 μg/
ml. MIC50 and MIC90 of COL was 4 and 8 μg/ml, re-
spectively. CAZ showed maximum MIC interval at 2 to
more than 2,048 μg/ml. Interestingly, most MDR-PA
isolates were resistant to MEM, CIP, and CAZ.
Fig. 2 Time killing assay of cinnamon bark oil and cinnamaldehyde. P. aeruginosa PAO1 (a) and MDR-PA (b) were collected to observe viable
cells after exposure to essential oils and incubated at 37 °C, 150 rpm. The results are expressed as mean values ± standard deviation of three
independent experiments
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Furthermore, synergistic interactions of ceftazidime,
piperacillin, ciprofloxacin, meropenem, imipenem, dori-
penem, colistin and cinnamon bark oil or its major
compound were further studied as a percentage of each
couple combinations. Thirty MDR-PA isolates were
tested in combination between antibiotics and cinnamon
bark oil or its major active compound. Most of the com-
binations exhibited indifferent interaction of two active
substances to bacterial isolates with FICI range of 0.5–4.
Synergistic rates could be detected in some isolates
which were at about 16.7 % in COL combined with
cinnamon bark oil, 10 % in COL combined with cinna-
maldehyde, and 3.3 % in MEM combined with cinnamon
bark oil. It was noteworthy that the antagonistic activities
were not be detected in any combinations (Table 3).
Cinnamon bark oil and cinnamaldehyde possessed
higher antibacterial activity of colistin and meropenem
against MDR-PA strains. Cinnamon bark oil was sug-
gested to act on bacterial membrane by dissipated potas-
sium cation (K+) gradient leading to membrane damage
and breakdown of permeability barrier resulting in cell
death [28]. Domadia et al. described the mechanism of
cinnamaldehyde which of bioactive compound was
assembled into Z-ring at the site of cell separation by
binding to FtsZ protein [29]. This data was an evidence
to show a reduction of bacterial cell loading.
Accumulation of various substances in cytoplasm and
destruction of cytoplasmic membrane of bacteria could
cause cellular substance leakage and cell death [30].
This might result in positive interaction in combin-
ation. Combination therapy is used for expanding the
antimicrobial spectrum, reducing toxicity and decreasing
the antimicrobial resistance during treatment. Moreover,
the results in this work showed no regrowth of P.
aeruginosa after exposed to cinnamon bark oil and
trans-cinnamaldehyde over 24 h.
Conclusions
Cinnamon bark oil is an essential oil obtained from the
bark of Cinnamomum zeylanicum which belongs to
Lauraceae family and usually grows in South and Southeast
Asia. The current study reported that cinnamon bark oil
and cinnamaldehyde possessed high bactericidal activity
against MDR-PA isolates. Moreover, it showed promising
tendency of combination with colistin, the currently used
drug for treatment of gram-negative bacterial infection.
Therefore, this could be a compound used for beneficial
human health, considering as an alternative therapeutic
agent for medical application and anti-bacterial supple-
ment in health products, especially natural active com-
pounds that might reduce the cost and could be safe.
However, the further studies including the in vivo toxicity
studies and clinical trials on cinnamon oil or its active
compound to determine pharmacodynamics and pharma-
cokinetics are still necessary.
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